logo

LUCD

Lucid Diagnostics·NASDAQ
--
--(--)
--
--(--)
1.07 / 10
Underperform

The equity presents a concerning fundamental picture with several key metrics in the lowest performance group (1/10). Inventory turnover days (23.21) and interest coverage ratio (15.48%) show moderate efficiency, but declining profitability is evident in Total profit (-22.82% YoY) and Net profit (-30.90% YoY) year-over-year declines. While fixed-asset utilization (0.97%) and liquidity (Quick ratio 1.88) remain acceptable, the overall fundamental score of 1.07 underscores weak earnings momentum and limited buffer against market volatility.

Fundamental(1.07)SentimentTechnical

Analysis Checks(4/10)

Total operating revenue (YoY growth rate %)
Value1.68
Score1/3
Weight13.42%
1M Return-3.52%
Quick ratio
Value1.88
Score1/3
Weight15.45%
1M Return-2.86%
Total profit (YoY growth rate %)
Value-22.82
Score1/3
Weight22.30%
1M Return-4.59%
Net cash flow from operating activities (YoY growth rate %)
Value1.06
Score1/3
Weight11.86%
1M Return-2.87%
Fixed assets turnover ratio
Value0.97
Score3/3
Weight-24.55%
1M Return4.11%
Long-term debt to working capital ratio (%)
Value0.05
Score2/3
Weight6.24%
1M Return-1.19%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight8.91%
1M Return-1.71%
Operating revenue (YoY growth rate %)
Value1.68
Score1/3
Weight13.42%
1M Return-3.52%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value-30.90
Score1/3
Weight23.66%
1M Return-5.11%
Inventory turnover days
Value23.21
Score2/3
Weight9.28%
1M Return-1.96%
Is LUCD undervalued or overvalued?
  • LUCD scores 1.07/10 on fundamentals and holds a Premium valuation at present. Backed by its -347.81% ROE, -1211.30% net margin, -2.48 P/E ratio, 6.50 P/B ratio, and 31.25% earnings growth, these metrics solidify its Underperform investment rating.